ClearSign director receives 3,766 stock options
The options were immediately vested and exercisable, with a $3.55 exercise price and a September 29, 2036 expiration date.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ClearSign Technologies Corp director Anthony Digiandomenico received 3,766 non-statutory stock options on September 30, 2026, as compensation for director services during the quarter ended September 30, 2026. The options were immediately vested and exercisable on the grant date, have a $3.55 exercise price per common share, and expire September 29, 2036.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Statutory Stock Options F1 | 3,766 | $0.00 | $0.00 |
Footnotes (1)
- F1. As compensation for services as a non-employee director during the quarter ended September 30, 2026, the reporting person was granted non-statutory stock options to purchase 3,766 shares of common stock under the ClearSign Technologies Corporation Amended and Restated 2021 Equity Incentive Plan pursuant to the issuer's non-employee director compensation policy. These non-statutory stock options were immediately vested and exercisable on the grant date.
Key Figures
Key Terms
Non-Statutory Stock Options financial
Amended and Restated 2021 Equity Incentive Plan financial
immediately vested and exercisable financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many options did CLIR director Anthony Digiandomenico receive?
When can Anthony Digiandomenico exercise the CLIR options, and when do they expire?
AI-generated analysis. How Rhea-AI works. Not financial advice.